BrainsWay Ltd.

Tel Aviv Stock Exchange:BWAY.TA

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

🩺 Medical Instruments

🧠 Mental Health

Location

Israel

Market Cap

USD 226.16 M

Share Price

USD 5.98

Avg Daily Volume

60,279

Change (1 day)

-0.06%

Change (1 year)

66.15%

Change (YTD)

30.62%

BrainsWay Ltd. EBITDA for the year ending December 31, 2024: USD 5.36 M

BrainsWay Ltd. EBITDA is USD 5.36 M for the year ending December 31, 2024, a -309.18% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

BrainsWay Ltd. EBITDA for the year ending December 31, 2023 was USD -2.56 M, a -77.64% change year over year.
BrainsWay Ltd. EBITDA for the year ending December 31, 2022 was USD -11.45 M, a 145.11% change year over year.
BrainsWay Ltd. EBITDA for the year ending December 31, 2021 was USD -4.67 M, a 34.90% change year over year.
BrainsWay Ltd. EBITDA for the year ending December 31, 2020 was USD -3.46 M, a -47.38% change year over year.